Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 25, 2014
Risk factors for radiotherapy incidents and impact of an online electronic reporting system
David W Chang, Lynn Cheetham, Luc te Marvelde, et al.
BJU International
|
February 12, 2017
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial
Shankar Siva, Daniel Pham, Tomas Kron, et al.
BMJ Open
|
March 8, 2014
Protocol for the ProCare Trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer
Jon Emery, Juanita Doorey, Michael Jefford, et al.
Physical and Engineering Sciences in Medicine
|
January 13, 2025
Guidance on selecting and evaluating AI auto-segmentation systems in clinical radiotherapy: insights from a six-vendor analysis
Branimir Rusanov, Martin A Ebert, Mahsheed Sabet, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
March 17, 2025
Treatment efficiency and quality improvement via double imaging modality (DIM) versus single imaging modality (SIM) image-guided radiotherapy for prostate cancer
Milad Mirzaei, Suki Gill, Mahsheed Sabet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2023
Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases
Shankar Siva, Pitchaya Sakyanun, Tao Mai, et al.
JAMA Oncology
|
August 29, 2021
Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial
Shankar Siva, Mathias Bressel, Tao Mai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 15, 2015
Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial
James W Denham, Allison Steigler, David Joseph, et al.
Physics and Imaging in Radiation Oncology
|
April 8, 2024
[18]F-fluoroethyl-l-tyrosine positron emission tomography for radiotherapy target delineation: Results from a Radiation Oncology credentialing program
Nathaniel Barry, Eng-Siew Koh, Martin A Ebert, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 25, 2014
Risk factors for radiotherapy incidents and impact of an online electronic reporting system
David W Chang, Lynn Cheetham, Luc te Marvelde, et al.
BJU International
|
February 12, 2017
Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial
Shankar Siva, Daniel Pham, Tomas Kron, et al.
BMJ Open
|
March 8, 2014
Protocol for the ProCare Trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancer
Jon Emery, Juanita Doorey, Michael Jefford, et al.
Physical and Engineering Sciences in Medicine
|
January 13, 2025
Guidance on selecting and evaluating AI auto-segmentation systems in clinical radiotherapy: insights from a six-vendor analysis
Branimir Rusanov, Martin A Ebert, Mahsheed Sabet, et al.
Technical Innovations & Patient Support in Radiation Oncology
|
March 17, 2025
Treatment efficiency and quality improvement via double imaging modality (DIM) versus single imaging modality (SIM) image-guided radiotherapy for prostate cancer
Milad Mirzaei, Suki Gill, Mahsheed Sabet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 14, 2023
Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases
Shankar Siva, Pitchaya Sakyanun, Tao Mai, et al.
JAMA Oncology
|
August 29, 2021
Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial
Shankar Siva, Mathias Bressel, Tao Mai, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 15, 2015
Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial
James W Denham, Allison Steigler, David Joseph, et al.
Physics and Imaging in Radiation Oncology
|
April 8, 2024
[18]F-fluoroethyl-l-tyrosine positron emission tomography for radiotherapy target delineation: Results from a Radiation Oncology credentialing program
Nathaniel Barry, Eng-Siew Koh, Martin A Ebert, et al.
Page
of 6